Hepatocellular carcinoma is one of the leading causes of cancer related death in the world.
Biannual surveillance for the disease in patients with cirrhosis and in high risk carriers of …

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. It
can be caused by chronic liver cell injury with resulting sustained inflammation, eg, triggered …

Hepatocellular carcinoma (HCC) is one of the leading causes of death from cancer in the
world. Recently, the effectiveness of new antiviral therapies and the HBV vaccine have …

Abstract Background Hepatocellular Carcinoma (HCC) remains the third most common
cause of cancer death worldwide, with countries in Asia being affected the most. The …

The high mortality rate of hepatocellular carcinoma (HCC) is primarily due to its late
diagnosis. In the past, numerous attempts have been made to design genetic biomarkers for …

Simple Summary Liver cancer is a growing problem around the world. Drugs for liver cancer
have limited effect, there are not enough donors for liver transplants and many patients are …

Hepatocellular carcinoma (HCC) is a common malignant tumor. At present, early diagnosis
of HCC is difficult and therapeutic methods are limited. Radiomics can achieve accurate …

BACKGROUND A wide range of ablative and non-surgical therapies are available for
treating small hepatocellular carcinoma in patients with very early or early-stage disease …

This study aimed to investigate the impact of ginger extract (GE) loaded into chitosan
nanoparticles (CNPs) in enhancing cytotoxicity and reducing cardiotoxicity of doxorubicin …

Abstract Background & Aims Non‐surgical therapies are frequently used for patients with
early or very early hepatocellular carcinoma (HCC). The aim of this systematic review and …